SENTYNL THERAPEUTICS- ON OPTION EXERCISE, SENTYNL TO COMMERCIALIZE ALVELESTAT IN U.S.; MEREO RETAINS REST OF WORLD RIGHTS

Reuters · 3d ago

Please log in to view news